Each capsule contains 500mcg Stable BPC-157, 500mcg KPV, 400mg PEA, 400mg Tributyrin
BPC-157 is a synthetic derivative of naturally occurring body protection compound (BPC), known for its anti-inflammatory and wound healing properties. BPC-157 is stable in human gastric juice, during prolonged storage, and when exposed to UV light. It possesses enhanced oral bioavailability (greater than 90%). Animal studies indicate that BPC157 may significantly improve gastrointestinal healing from ulcers, colitis, irritable bowel syndrome, and other inflammatory bowel diseases.
KPV is an anti-inflammatory peptide that has potential to help decrease inflammation in a wide range of intestinal diseases such as Crohn's disease and Ulcerative Colitis. It decreases the inflammatory response by inhibiting proinflammatory cytokine synthesis and secretion. KPV has been shown to stop the proinflammatory mechanisms in both intestinal epithelial cells and immune cells. KPV has shown promise in the case of Inflammatory Bowel Diseases through inhibited immune responses. KPV has also been shown to support healing of the mucosal lining of the gut which helps to stabilize Ulcerative Colitis. In one study KPV was given to mice with Ulcerative Colitis. These mice experienced significant improvements in body weight, colon length and disease symptoms.
PEA is a fatty acid amide molecule involved in a variety of cellular functions in chronic pain and inflammation. It has been shown to have neuroprotective, anti-inflammatory, anti-nociceptive (antipain) properties. The most important and promising indications for PEA are linked to neuropathic and chronic pain and inflammation such as gastro-intestinal inflammation, diabetic neuropathic pain, sciatic pain, CRPS, pelvic pain and entrapment neuropathic pain.
Tributyrin is a natural triglyceride that decreases inflammatory signaling by TNF-alpha, interleukin-1B, and interleukin-6. Studies show that Tributyrin regulates tight junctions to bolster intestinal barrier function. This may help to reduce the number of inflammatory particles that cross from the intestinal lumen (where food is) into the body, thereby preventing gut inflammation from starting. It also boosts expression of vitamin D3 receptors. Studies show that Tributyrin regulates tight junctions to bolster intestinal barrier function.Tributyrin may improve immune function, increase mucus production in the GI tract, and accelerate gastrointestinal wound healing.
Synergy Between BPC 157, KPV, PEA, and Tributyrin
Individually, BPC 157, PEA, Tributyrin, and KPV offer substantial benefits in fighting inflammation, particularly of the GI tract. In combination, the four act synergistically to regulate inflammation via several different but overlapping pathways. Together, these four compounds help produce enhanced anti-inflammatory effects by:
• reducing cyclooxygenase-2 signaling,
• substantially reducing TNF-alpha levels,
• activating nuclear transcription factors responsible for controlling the immune system,
• improving gastric mucous secretion and function
• enhancing intestinal barrier function.
Gut inflammation research capsules contain 250mcg Stable BPC-157 Arginate Form, 500mcg Larazotide, 500mcg KPV. This research product has the ability to treat numerous gut problems such as gluten intolerance, inflammatory bowel disease, and auto-immune diseases such as Type 1 diabetes and Hashimoto’s thyroiditis.
PRODUCT USAGE WARNING : This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
